The 6th ACTO meeting will be held in Gwangju, Korea on August 20 and 21 of 2015 year.
The detailed information will be announced as soon as possible.

The 5th ACTO annual meeting and satellite symposium in Osaka were successfully completed by the support of speakers, chairs, attendees and sponsors.
Thank you for your cooperation and support.
Looking forward to meeting you in Gwangju, Korea for the 6th ACTO meeting on August 20-22, 2015.

The 5th Meeting information site

“The 5th Meeting of ACTO” will be held on Nov 9-12, 2014 at Osaka.
We will informed you of the detailed in our next message.

>> The 5th Meeting information site (http://acto2014.info/)

It is our great pleasure to announce that the fourth meeting of Asian Cellular Therapy Organization (ACTO) has been scheduled from July 18th to 20th, 2013, at the National Health Research Institue (NHRI), Zhu-Nan, Taiwan.

The main purpose of this meeting is for researchers, clinicians, business persons and regulators to share knowledge and expertise regarding the development of equipment and treatments in the field of cellular therapy, i.e. hematopoietic stem cell transplantation, immunotherapy, regenerative medicine and gene therapy.

In most Asian countries, expertise in innovative cellular therapy and the development of equipment for clinical use have not been well explored. Additionally, regulatory guidelines for approval processes have not yet been firmly established, although these are essential for the development of new ideas for clinical application. These are serious obstacles for the development of our own research seeds. In this meeting, we expect to have an active discussion in a rather informal atmosphere, and will cover a variety of topics regarding cellular therapy. We believe that this meeting will help enhance communications between Asian researchers and regulators.

Your participation will be critical to make this meeting successful. We look forward to an exciting event and to seeing you in Zhu-Nan, Taiwan!

Sincerely yours,

President
Yao-Chang, Chen M.D.
President of ACTO2013
Professor, Department of Laboratory Medicine
National Taiwan University Hospital

The 4th Meeting Information Site (http://www.acto2013.org)

Dear Colleagues,

On behalf of the Asian Cellular Therapy Organization and the Thai Society of Hematology, we have a great pleasure to invite you to attend the 3rd Meeting of Asian Cellular Therapy Organization (ACTO 2012) which will be held at the Le Méridien, Chiangmai, Thailand during November 15-17, 2012. This meeting is intended to present the most up-to-date scientific discussion of the development of equipment and treatments in the field of cellular therapy on hematopoietic stem cell transplant, immunotherapy, regenerative medicine, gene therapy and regulatory issue. The scientific session will give all participants a chance to share the latest knowledge and experience.

Please be announced that early registration and abstract submission for the ACTO 2012 is now open. We also would like to invite you to present your research work as the oral or poster presentation in the meeting.

The deadline for early registration and abstract submission is September 30, 2012. For further information, please visit our website at http://www.acto2012.org .

If you have any questions or need assistance, please contact the secretariat by email. We look forward to your participation in ACTO 2012 in this coming November.

Yours sincerely,

Secretariat of ACTO 2012
c/o The Thai Society of Hematology
10th Floor, the Royal Golden Jubilee Bldg.
2 SoiSoonvijai, New Petchburi Road
Bangkok 10210
Phone: +662 716-5977
Fax: +662 716-5978
Email: secretariat@acto2012.org
      Joi_kt@hotmail.com

Invitation Letter to the 3rd Meeting of ACTO

Dear ISCT Asia members

It is our pleasure to announce that ISCT Asian Regional Meeting changed to a new academic society named ACTO (Asian Cellular Therapy Organization).

ISCT Asia was one of to branch societies of ISCT (International Society for Cellular Therapy) as ISCT-Europe and ISCT-Australia/New-Zealand. From last year, these regional operations have appealed that the autonomous regional activity independent of ISCT HQ was important for region-oriented development of cellular therapy.

On May 2011, our Asian group decided to establish a new group for progress of cellular therapy more based on Asian situation. Along with the independence from ISCT, the name was changed to ACTO by many members’ suggestions.

Even though the name was changed, the aim and activity of our society continue without change. The 2nd Meeting will also be held on October 17-20, 2011 at Miyazaki, like as last year, named as “The 2nd Meeting of ACTO”.

It would be greatly appreciated if you worked together for the new Asian Cellular Therapy Organization.

Sincerely,
Akihiro Shimosaka, Ph. D,
Chairperson, ACTO

Senior Research Adviser
Division of Stem Cell Therapy
Center for Stem Cell Biology and Regenerative Medicine
The Institute of Medical Science,
The University of Tokyo

Director
Research and Development Division
Research Foundation for Community Medicine

P.S.

This year, the 3rd meeting of ACTO will be held in Chiang Mai,
Thailand on Nov.16 and 17, 2012. We will give you further
information about it as soon as possible.